Key result
18F-FDG PET/CT successfully detected a left atrial myxoma with moderately elevated glucose metabolism, which correlated with intense immunohistochemical GLUT-1 expression in the tumor cells.
Case Report (n=1)
No
18F-FDG PET/CT can successfully detect cardiac myxomas, with FDG uptake potentially correlating with enhanced GLUT-1 expression in the tumor cells.
Answers are grounded in this paper and cite their sources.
FDG-PET uptake in left atrial myxoma correlates with GLUT-1; leaves open diagnostic utility pending prospective validation.
Cardiac tumours are relatively rare and are difficult to diagnose merely with imaging techniques. We demonstrated an unusual case of left atrial myxoma, displaying the successful detection by positron emission tomography using 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG PET), correlated closely to more intense and enhanced immunoreactivity with glucose transporter-1 (GLUT-1) in a substantial number of cardiac myxoma cells. Further prospective studies are needed to validate the significance of 18 F-FDG PET findings for cardiac myxoma and the association with immunohistochemical GLUT-1 expression in its tumour cells, after collecting and investigating a larger number of surgical cases examined with both of them. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2991481941253449.
No takes yet. Share an insight, caveat, or question.
Okazaki et al. (2014) conducted a case report in Cardiac myxoma (n=1). 18F-FDG PET/CT was evaluated on Detection of cardiac myxoma and GLUT-1 expression. 18F-FDG PET/CT successfully detected a left atrial myxoma with moderately elevated glucose metabolism, which correlated with intense immunohistochemical GLUT-1 expression in the tumor cells.
Synapse has enriched 10 related papers. Consider them for comparative context: